A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
- Author
- YUNG, W. K. A1 ; ALBRIGHT, R. E2 ; GLANTZ, M11 ; GREENBERG, H12 ; SELKER, R. G13 ; VICK, N. A14 ; RAMPLING, R15 ; FRIEDMAN, H16 ; PHILLIPS, P17 ; BRUNER, J1 ; YUE, N18 ; OSOBA, D19 ; OLSON, J3 ; ZAKNOEN, S20 ; LEVIN, V. A1 ; FREDERICKS, R4 ; FINK, K5 ; PRADOS, M. D6 ; BRADA, M7 ; SPENCE, A8 ; HOHL, R. J9 ; SHAPIRO, W10
[1] UTMD Anderson Cancer Center, Department of Neuro-Oncology, Box 100, 1515 Holcombe Boulevard, Houston, Texas 77030, United States
[2] Barret Cancer Center, 234 Goodman Street, Cincinnati, Ohio 45267, United States
[3] Emory University, Department of Neurosurgery, 1327 Clifton Road, Atlanta, Georgia 30322, United States
[4] University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216, United States
[5] University of Texas, Southwestern Medical School, Department of Neurology, 5323 Harry Hines Boulevard, Dallas, Texas 75235, United States
[6] University of California, San Francisco, Department of Neurosurgery, 533 Parnassus Street, Room U107, San Francisco, California 94143, United States
[7] The Royal Marsden NHS Trust and the Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom
[8] University of Washington, Department of Neurology, Box 356465, 1959 N.E. Pacific Street, Seattle, Washington 98195, United States
[9] University of Iowa, Hospitals and Clinics, 200 Hawkins Drive, Iowa City, Iowa 52242, United States
[10] Barrow Neurological Institute, Division of Neurology, 350 West Thomas Road, Phoenix, Arizona 85013, United States
[11] Memorial Hospital of Rhode Island, 710 Robinson Road, PO Box 665, Hinsdale, Massachusetts 01235, United States
[12] University of Michigan Medical Center, Department of Neurology, 1500 East Medical Center Drive, 1914 Taubman Center, Box 0316, Ann Arbor, Michigan 48109, United States
[13] West Penn Hospital, Center for Neuro-Oncology, 4800 Friendship Avenue - Suite 1614, Pittsburgh, Pennsylvania 15224, United States
[14] Evanston Hospital, Division of Neurology, 2650 Ridge Avenue, Evanston, Illinois 60201, United States
[15] Beatson Oncology Centre, Western Infirmary, Glasgow G11 6NT, United Kingdom
[16] Duke University Medical Center, Department of Pediatric Hematology-Oncology, Duke North - Room 5418, Erwin Road, Durham, North Carolina 27710, United States
[17] University of Pennsylvania Medical Center, Department of Neuroscience, Abramson 516, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United States
[18] MRI Reading Center at St. Joseph, 8216 Carrbridge Circle, Baltimore, Maryland 21204, United States
[19] British Columbia Cancer Agency, 1515 Larch Street, Vancouver, British Columbia, V6K 3N6, Canada
[20] Schering-Plough Research Institute, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United Kingdom - Source
British journal of cancer. 2000, Vol 83, Num 5, pp 588-593 ; ref : 30 ref
- CODEN
- BJCAAI
- ISSN
- 0007-0920
- Scientific domain
- Medical oncology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Chimiothérapie Courbe survie Essai clinique phase II Etude comparative Etude multicentrique Glioblastome multiforme Homme Procarbazine Qualité vie Témozolomide Gliome malin Système nerveux central pathologie Système nerveux pathologie Tumeur maligne
- Keyword (en)
- Antineoplastic agent Chemotherapy Survival curve Phase II trial Comparative study Multicenter study Glioblastoma multiforme Human Procarbazine Quality of life Temozolomide Malignant glioma Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Anticanceroso Quimioterapia Curva sobrevivencia Ensayo clínico fase II Estudio comparativo Estudio multicéntrico Glioblastoma multiforme Hombre Procarbazina Calidad vida Temozolomida Glioma maligno Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Neurology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1473961
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1054/bjoc.2000.1316 
https://dx.doi.org/10.1054/bjoc.2000.1316
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"83\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"588\";s:8:\"\u0000*\u0000epage\";s:3:\"593\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YUNG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"W. K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:14:\"ALBRIGHT, R. E\";i:1;s:9:\"GLANTZ, M\";i:2;s:12:\"GREENBERG, H\";i:3;s:12:\"SELKER, R. G\";i:4;s:10:\"VICK, N. A\";i:5;s:11:\"RAMPLING, R\";i:6;s:11:\"FRIEDMAN, H\";i:7;s:11:\"PHILLIPS, P\";i:8;s:9:\"BRUNER, J\";i:9;s:6:\"YUE, N\";i:10;s:8:\"OSOBA, D\";i:11;s:8:\"OLSON, J\";i:12;s:10:\"ZAKNOEN, S\";i:13;s:11:\"LEVIN, V. A\";i:14;s:13:\"FREDERICKS, R\";i:15;s:7:\"FINK, K\";i:16;s:12:\"PRADOS, M. D\";i:17;s:8:\"BRADA, M\";i:18;s:9:\"SPENCE, A\";i:19;s:10:\"HOHL, R. J\";i:20;s:10:\"SHAPIRO, W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"83\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"588\";s:8:\"\u0000*\u0000epage\";s:3:\"593\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YUNG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"W. K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:14:\"ALBRIGHT, R. E\";i:1;s:9:\"GLANTZ, M\";i:2;s:12:\"GREENBERG, H\";i:3;s:12:\"SELKER, R. G\";i:4;s:10:\"VICK, N. A\";i:5;s:11:\"RAMPLING, R\";i:6;s:11:\"FRIEDMAN, H\";i:7;s:11:\"PHILLIPS, P\";i:8;s:9:\"BRUNER, J\";i:9;s:6:\"YUE, N\";i:10;s:8:\"OSOBA, D\";i:11;s:8:\"OLSON, J\";i:12;s:10:\"ZAKNOEN, S\";i:13;s:11:\"LEVIN, V. A\";i:14;s:13:\"FREDERICKS, R\";i:15;s:7:\"FINK, K\";i:16;s:12:\"PRADOS, M. D\";i:17;s:8:\"BRADA, M\";i:18;s:9:\"SPENCE, A\";i:19;s:10:\"HOHL, R. J\";i:20;s:10:\"SHAPIRO, W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"83\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"588\";s:8:\"\u0000*\u0000epage\";s:3:\"593\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YUNG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"W. K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:14:\"ALBRIGHT, R. E\";i:1;s:9:\"GLANTZ, M\";i:2;s:12:\"GREENBERG, H\";i:3;s:12:\"SELKER, R. G\";i:4;s:10:\"VICK, N. A\";i:5;s:11:\"RAMPLING, R\";i:6;s:11:\"FRIEDMAN, H\";i:7;s:11:\"PHILLIPS, P\";i:8;s:9:\"BRUNER, J\";i:9;s:6:\"YUE, N\";i:10;s:8:\"OSOBA, D\";i:11;s:8:\"OLSON, J\";i:12;s:10:\"ZAKNOEN, S\";i:13;s:11:\"LEVIN, V. A\";i:14;s:13:\"FREDERICKS, R\";i:15;s:7:\"FINK, K\";i:16;s:12:\"PRADOS, M. D\";i:17;s:8:\"BRADA, M\";i:18;s:9:\"SPENCE, A\";i:19;s:10:\"HOHL, R. J\";i:20;s:10:\"SHAPIRO, W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"83\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"588\";s:8:\"\u0000*\u0000epage\";s:3:\"593\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YUNG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"W. K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:14:\"ALBRIGHT, R. E\";i:1;s:9:\"GLANTZ, M\";i:2;s:12:\"GREENBERG, H\";i:3;s:12:\"SELKER, R. G\";i:4;s:10:\"VICK, N. A\";i:5;s:11:\"RAMPLING, R\";i:6;s:11:\"FRIEDMAN, H\";i:7;s:11:\"PHILLIPS, P\";i:8;s:9:\"BRUNER, J\";i:9;s:6:\"YUE, N\";i:10;s:8:\"OSOBA, D\";i:11;s:8:\"OLSON, J\";i:12;s:10:\"ZAKNOEN, S\";i:13;s:11:\"LEVIN, V. A\";i:14;s:13:\"FREDERICKS, R\";i:15;s:7:\"FINK, K\";i:16;s:12:\"PRADOS, M. D\";i:17;s:8:\"BRADA, M\";i:18;s:9:\"SPENCE, A\";i:19;s:10:\"HOHL, R. J\";i:20;s:10:\"SHAPIRO, W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1054\/bjoc.2000.1316\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"83\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"588\";s:8:\"\u0000*\u0000epage\";s:3:\"593\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YUNG\";s:10:\"\u0000*\u0000aufirst\";s:7:\"W. K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:21:{i:0;s:14:\"ALBRIGHT, R. E\";i:1;s:9:\"GLANTZ, M\";i:2;s:12:\"GREENBERG, H\";i:3;s:12:\"SELKER, R. G\";i:4;s:10:\"VICK, N. A\";i:5;s:11:\"RAMPLING, R\";i:6;s:11:\"FRIEDMAN, H\";i:7;s:11:\"PHILLIPS, P\";i:8;s:9:\"BRUNER, J\";i:9;s:6:\"YUE, N\";i:10;s:8:\"OSOBA, D\";i:11;s:8:\"OLSON, J\";i:12;s:10:\"ZAKNOEN, S\";i:13;s:11:\"LEVIN, V. A\";i:14;s:13:\"FREDERICKS, R\";i:15;s:7:\"FINK, K\";i:16;s:12:\"PRADOS, M. D\";i:17;s:8:\"BRADA, M\";i:18;s:9:\"SPENCE, A\";i:19;s:10:\"HOHL, R. J\";i:20;s:10:\"SHAPIRO, W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
